Physician profile
Michael D Callan
NPI 1568671964
$4,461.58
in general payments reported to CMS, 2019-2025
10 companies · $538 in 2025
The $538 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $269 · 2021: $175 · 2022: $1,480 · 2023: $521 · 2024: $921 · 2025: $538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,980.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,980.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,807.47 | 2019-2025 | Tapestry, A.L.P.S., Synovasure Alpha Defensin |
| Avanos Medical | $900.10 | 2019-2024 | On-Q* Pump and Accessories |
| Stryker Corporation | $439.69 | 2020-2025 | Gamma, T2 Alpha |
| Smith+Nephew, INC. | $413.75 | 2019-2022 | |
| Depuy Synthes Sales INC. | $226.23 | 2019-2024 | Na |
| Medical Device Business Services, INC. | $181.67 | 2022 | |
| Innovation Technologies INC | $145.41 | 2022 | |
| Paragon 28, INC. | $125.28 | 2024 | R3flex |
| Davol INC. | $119.48 | 2022 | |
| Pacira Therapeutics, INC. | $102.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Callan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.